Flexibility in assessment of rare disease technologies via NICE's single technology appraisal route: a thematic analysis

AIM: NICE's highly specialized technology (HST) evaluations are highly restrictive in terms of entry criteria and as a consequence, the vast majority of rare disease medicines are assessed through NICE's standard, single technology appraisal (STA) route. We explored whether NICE shows flex...

Descripción completa

Detalles Bibliográficos
Autores principales: Hale, George, Morris, James, Barker-Yip, Jules
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690432/
https://www.ncbi.nlm.nih.gov/pubmed/37724717
http://dx.doi.org/10.57264/cer-2023-0093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690432/
https://www.ncbi.nlm.nih.gov/pubmed/37724717
http://dx.doi.org/10.57264/cer-2023-0093

Ejemplares similares